{
    "2021-02-20": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|孙建】周报：「恐高」回调，坚守主线",
                "features": {
                    "keywords": [
                        "恐高",
                        "回调",
                        "坚守",
                        "主线"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基因测序一周风云榜：金域医学市值半月蒸发七分之一，药明康德市值稳居首位 连续下跌",
                "features": {
                    "keywords": [
                        "基因测序",
                        "金域医学",
                        "市值蒸发",
                        "药明康德",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "基因测序"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}